NIHR data reveals commercial study set up times reduce by a third
Over 600 commercial studies have been reviewed in the past 12 months
Read More
Tag: National Contract Value Review
- Lario Therapeutics awarded $2.4m to advance calcium channel platform
- Mikrobiomik secures approval for gut‑microbiota therapy for C difficile infection
- Exdensur approved in EU for severe asthma and CRSwNP
- Axol Bioscience acquires Newcells Biotech ophthalmology unit
- Nuclera and leadXpro partner to accelerate structure‑based drug design
